Vestal Point Capital, LP

Holdings History for Enliven Therapeutics, Inc. - Common Stock, par value $0.001 per share (ELVN)

Symbol: ELVN on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 3,830,000 shares
Security Ownership %: 6.5%

Shares, Excluding Options vs Price

Value, Excluding Options

Vestal Point Capital, LP ownership in Enliven Therapeutics, Inc. Common Stock, par value $0.001 per share (ELVN)

17 Feb 2026 - Vestal Point Capital, LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,830,000 shares of Enliven Therapeutics, Inc. Common Stock, par value $0.001 per share (ELVN). This represents 6.5% ownership of the company. This is the first filing by Vestal Point Capital, LP disclosing ownership of Enliven Therapeutics, Inc. Common Stock, par value $0.001 per share (ELVN).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Vestal Point Capital, LP	6.5%		$98,622,500	3,830,000			$25.75	13G	31 Dec 2025	17 Feb 2026, 16:07

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	2.2%	+1.5%	$58,982,000	3,830,000	+2,670,000	+230%	$15.40	Q4 2025
30 Sep 2025	1.1%	+0.85%	$23,745,200	1,160,000	+910,000	+364%	$20.47	Q3 2025
30 Jun 2025	0.26%	+0.26%	$5,015,000	250,000	+250,000	NEW	$20.06	Q2 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.